NCT07142811Phase 2Active not recruiting

A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV Infection

Study sponsor: Vir Biotechnology, Inc. · VIR

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2029-03Estimated
Enrollment · participants100Estimated
Source updated2026-11-17Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: Nov 2026. After: Mar 2029.

Check registry source

· 1 field changed

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source